As luck would have it, new developments in biotechnology provided an alternate source for insulin. Recombinant DNA, a lab technique developed in the early 1970s, allowed pharmaceutical manufacturers ...

After figuring out how to grow recombinant bacteria on an industrial scale and how to harvest the insulin they produce, it was time to bring the recombinant insulin to the market. In 1982 Food and ...

For example, recombinant insulin for diabetes now accounts for more than 70% of the worldwide human insulin market. Other successful recombinant products include erythropoietin, interferon alpha ...

Genetic engineering deployed to insert gene for human insulin into a bacterium, thus harnessing the substance for widespread ...

It was also responsible for the first recombinant insulin product – Humulin – which launched in 1982 and remains on sale. Insulin products remain a multibillion-dollar business for the company ...

Brazilian President Luiz Inácio Lula da Silva Friday participated in the city of Nova Lima, state of Minas Gerais, in the opening of the Biomm recombinant human insulin-producing plant.

But the question on many minds is: does this represent the death knell for the inhaled-insulin market? Developing Exubera (recombinant human insulin with particle diameters between 1 and 5 mm ...